<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9"><gtr:id>31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9</gtr:id><gtr:name>MRC Human Immunology Unit</gtr:name><gtr:address><gtr:line1>Weatherall Inst of Molecular Medicine</gtr:line1><gtr:line2>John Radcliffe Hospital</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 9DS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9"><gtr:id>31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9</gtr:id><gtr:name>MRC Human Immunology Unit</gtr:name><gtr:address><gtr:line1>Weatherall Inst of Molecular Medicine</gtr:line1><gtr:line2>John Radcliffe Hospital</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 9DS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3977BEDB-7FAD-4EED-BF70-54E0D45DD4FA"><gtr:id>3977BEDB-7FAD-4EED-BF70-54E0D45DD4FA</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Bowness</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U137884185"><gtr:id>CAC5E84A-CCA3-4451-97CA-3B6A776EDB77</gtr:id><gtr:title>The role of HLA B27 in spondylarthropathy</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U137884185</gtr:grantReference><gtr:abstractText>a) Nature of research HLA-B27 is a tissue type found in approximately 9 % of the population, but over 95% of patients with a common form of arthritis called Ankylosing Spondylitis (AS). How HLA-B27 causes disease is mysterious. Our work has shown that HLA-B27 can fold in an unusual way to form dimers, and that these dimers can stimulate T and Natural Killer blood lymphocytes and other cells of the immune system. The possibility that this leads to the disease is being explored in studies on laboratory and patient cells. We are also trying to make reagents that will block the interaction of B27 dimers with these receptors.||b) prospective outcomes - Better understanding of the mechanisms underlying autoimmune diseases, particularly AS and Reactive arthritis) health benefits - Potential for improved management of autoimmune arthritis</gtr:abstractText><gtr:technicalSummary>Summary and aims of project||We hypothesise that HLA B27 causes spondyloarthritis either through its ability to bind and present arthritogenic peptides to T lymphocytes, or through its ability to form an aberrant dimeric structure which lacks beta2 microglobulin.||We will study the biochemistry of HLA B27 in various transfected cell lines, in order to determine which factors control homodimer formation. We will also use newly developed tetramer technology to study patient blood samples. This will involve the production of protein in E coli and in vitro folding of HLA B27 homodimers, and the use of fluorescent tagged HC-B27 tetramers to identify the ligands on different cell types of patients with spondylarthritis.||We are also studying the peptide binding specificity of B27 dimers and their specificity for different known ligands including the Natural Killer receptors and the Leukocyte Ig-like receptors (LILR).||Experimental design||a) Human blood and synovial fluid cells.|b) techniques/approaches - cellular immunology; protein expression and purification; molecular biology.|c) measurements/outcomes - Better understanding of the mechanisms underlying autoimmune diseases particularly AS and Reactive Arthritis</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1998-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>660515</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Medicine</gtr:department><gtr:description>Proteomics of SPondyloarthritis</gtr:description><gtr:id>D6EEA7A5-071A-4D2A-A5C4-7D6C9ED0DE0D</gtr:id><gtr:impact>PMID: 18952638</gtr:impact><gtr:outcomeId>FFDF3CBB421-1</gtr:outcomeId><gtr:partnerContribution>Scientific collaboration</gtr:partnerContribution><gtr:piContribution>scientific collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Medicine</gtr:department><gtr:description>anti-viral immunity</gtr:description><gtr:id>997C4E72-C598-437C-8A1E-257D11147843</gtr:id><gtr:impact>PMID: 19139562</gtr:impact><gtr:outcomeId>1EA1A74E433-1</gtr:outcomeId><gtr:partnerContribution>scientific collaboration</gtr:partnerContribution><gtr:piContribution>reagents and collab experimetns</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>magazine Q and A</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>693DBDCB-54CD-489B-9BC9-D5AD385707E3</gtr:id><gtr:impact>Arthritis magazine</gtr:impact><gtr:outcomeId>LodsCGdV2mk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture and review article</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>92445086-F495-41B3-BB12-B76146C37E3C</gtr:id><gtr:impact>1) lecture at RCP Advanced Medicine conference. 2) Bowness P Kollnberger S, and Chan A. Recent advances in Spondyloarthritides; in Horizons in Medicine 19 (RCP) Ed David Lomas. 2008

Education of physicians</gtr:impact><gtr:outcomeId>784CBBF87E8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>published interview</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>81358576-19AE-40BA-BC30-07082F27224F</gtr:id><gtr:impact>published interview</gtr:impact><gtr:outcomeId>A98AC40DF7D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4BADBA11-5C4A-4A5A-8A86-95F21271432E</gtr:id><gtr:impact>talk
&amp;gt;60
AHP
Drs
Public attended</gtr:impact><gtr:outcomeId>fgNCaeSadCc</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>book chapter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0009E1F5-E251-49DA-B239-5C788D5DEDBB</gtr:id><gtr:impact>Kollnberger S and Bowness P. Book Chapter in Spondyloarthropathies 2009

Kollnberger S and Bowness P. Book Chapter in Spondyloarthropathies 2009 PMID: 19731637</gtr:impact><gtr:outcomeId>B0D17A49E9C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>9th International Congress on Spondyloarthropathies</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B86D1679-F750-46D6-A7F3-BBCEB8AE33FC</gtr:id><gtr:impact>Plenary talk (750 delegates) to foremost international meeting
Friday 24th oct 2014 Gent
Title &amp;quot; HLA-B27 antigen presentation and ERAP1&amp;quot;
talk sparked multiple questions and discussion afterwards

After talk, one current Rheumatology trainiee asked to visit and work in my lab</gtr:impact><gtr:outcomeId>545a38ca7a5cd7.24890585</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.eiseverywhere.com/ereg/record.php?id=QOwxyaYJrweXrG2JYzxiTw%3D%3D</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>visiting professor</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>677A3803-58A9-4263-81D3-F3986EFBE434</gtr:id><gtr:impact>Toronto
jan 2013
3 lectures

Toronto
jan 2013
3 lectures
&amp;gt;200 attendees</gtr:impact><gtr:outcomeId>pAcm1Rpnrap</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5127D684-38DE-4E7C-85FC-05DE3B848C40</gtr:id><gtr:impact>Autoimmunity - when our bodies turn on us
Public Talk
FREE entry, everyone is welcome
For more information on NIHR Oxford BRC www.oxfordbrc.nihr.ac.uk
National Institute forHealth Research
Thursday 11th June 2015
Time: Refreshments from 6:00 pm for a 6:30 pm start
Location: Nuffield Orthopaedic Centre - Lecture Theatre Level 1, Windmill Rd,
Oxford OX3 7LD
Autoimmunity -

&amp;gt;60 interested public members
BBC</gtr:impact><gtr:outcomeId>5564952df28b65.80100536</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.oxfordbrc.nihr.ac.uk</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>140000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ARC Project Grant</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>393DF192-AA3E-4155-97A1-18B246F39645</gtr:id><gtr:outcomeId>DC88C7B6EBD0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>160000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Action Medical Research, Project Grant</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Action Medical Research</gtr:fundingOrg><gtr:id>1584C30E-0DF4-45E1-A899-F9A3BEECE649</gtr:id><gtr:outcomeId>A13A19507830</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>81000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ARC PhD Studentship</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>FFCD3B4C-FD62-43CF-B16E-31344A9EE776</gtr:id><gtr:outcomeId>2DB2D5F8D4B0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Assistant editor Arthritis and Rheumatology</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>82F1FCB2-3267-4644-8A52-EA5DAF3A26CF</gtr:id><gtr:impact>Assistant editor Arthritis and Rheumatology, invovlved in reviewing of publications</gtr:impact><gtr:outcomeId>545a3e561c96d5.33564019</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ASAS</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>ASAS criteria</gtr:guidelineTitle><gtr:id>7E913777-8B6E-4643-8766-44521B775496</gtr:id><gtr:impact>new expert treatments and diagnosis guidelines set out
ASAS

additional meetings including jan 2106 Berlin</gtr:impact><gtr:outcomeId>rhGXjx8K2EG</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Analysis of repertoire of peptides bound to HLA-B27 by tandem semi-quantitative mass spectrometry</gtr:description><gtr:id>E08132D1-21DD-4611-B884-83D177F19ED2</gtr:id><gtr:impact>Novel primary research publication in Arthritis And Rheumatism 2012 &amp;quot;ERAP1 plays a critical role in determining the length and sequence of peptides bound and presented by HLA-B27&amp;quot; Chen.... and Bowness</gtr:impact><gtr:outcomeId>rLgB1kBwiUQ</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Analysis of repertoire of peptides bound to HLA-B27 by msms</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>lentiviral siRNA Silencing of ERAP1 and reintroduction of siRNA resistatnt ERAP1 alleles</gtr:description><gtr:id>6ACF850D-5213-4AF9-8E16-4BD0C5759891</gtr:id><gtr:impact>potential for studying polymorphic molecules in human cell lines
reduced use of animals/animal-derived cells</gtr:impact><gtr:outcomeId>545a3baf09ba39.59584396</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>lentiviral siRNA Silencing of ERAP1 and reintroduction of siRNA resistatnt ERAP1 alleles</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Stewart-Jones GB, di Gleria K, Kollnberger S, McMichael AJ, Jones EY, Bowness P. Abstract Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Eur J Immunol. 2005 Feb;35(2):341-51. McMichael and Paul Bowness . Arthritis Rheum. (2002). 46. 11. 2972-82.</gtr:description><gtr:id>EFBD76F7-90A2-48C4-9A00-25156C5AEF77</gtr:id><gtr:impact>papers widely quoted</gtr:impact><gtr:outcomeId>A93003C8009</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>crystal structures of B27 and viral epitopes</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0155FCB1-AB62-48F6-BDCB-8B445D0AE2BC</gtr:id><gtr:title>Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+ and CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6981f26c03353bc4732c592ab426826a"><gtr:id>6981f26c03353bc4732c592ab426826a</gtr:id><gtr:otherNames>Black AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>7A72A248440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8E4BCAC-B3C1-448D-AC73-EC73066044BE</gtr:id><gtr:title>CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87298eb25e04df0efe4e16f397cbf682"><gtr:id>87298eb25e04df0efe4e16f397cbf682</gtr:id><gtr:otherNames>Chan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>3D3E6C3DE95</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DA05898-37B2-4D37-BA81-610BF6464354</gtr:id><gtr:title>Ankylosing spondylitis monocytes show upregulation of proteins involved in inflammation and the ubiquitin proteasome pathway.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aadfa34ae89a91eae155529095a9f159"><gtr:id>aadfa34ae89a91eae155529095a9f159</gtr:id><gtr:otherNames>Wright C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>DCC3CF14804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>834AED24-7BC5-45BB-BB7D-E35BE808232F</gtr:id><gtr:title>Broad TCR usage in functional HIV-1-specific CD8(+) T cell expansions driven by vaccination during highly active antiretroviral therapy</gtr:title><gtr:parentPublicationTitle>JOURNAL OF IMMUNOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81aa125de64bc9353ff75a3400db572f"><gtr:id>81aa125de64bc9353ff75a3400db572f</gtr:id><gtr:otherNames>Yang Hongbing</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>00C14E42081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0FFD7CE-BDC8-452A-8D44-A7CDACC4C9B7</gtr:id><gtr:title>Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondylarthritis by interactions between fibroblast-like synoviocytes and natural killer cells.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87298eb25e04df0efe4e16f397cbf682"><gtr:id>87298eb25e04df0efe4e16f397cbf682</gtr:id><gtr:otherNames>Chan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>74BB984C7C5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5FAFF52-A0E1-4F92-8C79-78F19DE686B7</gtr:id><gtr:title>Evolution of CD8+ T cell responses after acute PARV4 infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48b41a7bf26cc5bdd6192b93f1e3b8e5"><gtr:id>48b41a7bf26cc5bdd6192b93f1e3b8e5</gtr:id><gtr:otherNames>Simmons R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13770_20_23283958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7486F84B-5427-44A6-B4C1-558DE8EEF933</gtr:id><gtr:title>Aberrant cellular immune responses in humans infected persistently with parvovirus B19.</gtr:title><gtr:parentPublicationTitle>Journal of medical virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/595150731f9c06e9b61ff98ee3e55312"><gtr:id>595150731f9c06e9b61ff98ee3e55312</gtr:id><gtr:otherNames>Isa A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0146-6615</gtr:issn><gtr:outcomeId>425244E1063</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DF435E7-E672-401B-80AD-38495393AD01</gtr:id><gtr:title>Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/acad9a3b55b56611a7d851297c9f6445"><gtr:id>acad9a3b55b56611a7d851297c9f6445</gtr:id><gtr:otherNames>Neumann-Haefelin C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>Z7C5Jb7WHpF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7AC808D-EB84-4A44-B8CE-615024A36D08</gtr:id><gtr:title>The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52db1477c3d55ad548973c3b445f22bb"><gtr:id>52db1477c3d55ad548973c3b445f22bb</gtr:id><gtr:otherNames>Cauli A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>pm_13770_20_23804219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>236EA230-0519-423D-A3F6-4562E0553C90</gtr:id><gtr:title>Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da746618b1b17a25497b2235af69178a"><gtr:id>da746618b1b17a25497b2235af69178a</gtr:id><gtr:otherNames>Dorrell L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>12D900CC983</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFFB8D3C-B815-4A3B-A16A-600189A3106F</gtr:id><gtr:title>A highly restricted T-cell receptor dominates the CD8+ T-cell response to parvovirus B19 infection in HLA-A*2402-positive individuals.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d588795d77f60abde584e2f6fc73eb3"><gtr:id>2d588795d77f60abde584e2f6fc73eb3</gtr:id><gtr:otherNames>Kasprowicz V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>1E71C768154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11A42E5E-8423-4B1E-BEA8-09D7C25C61E7</gtr:id><gtr:title>Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15677618d190f121dd682fd99401149d"><gtr:id>15677618d190f121dd682fd99401149d</gtr:id><gtr:otherNames>Billerbeck E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>YEcftWC1CUP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E3F65DE-CAA5-4063-B79C-1297117D63BD</gtr:id><gtr:title>Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ec51e36c75b23360381eb18fff1bf81"><gtr:id>3ec51e36c75b23360381eb18fff1bf81</gtr:id><gtr:otherNames>Dazert E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>544AA0E0F82</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6BD2B27-C9CE-48E8-A5F3-170CA2143D43</gtr:id><gtr:title>Consistent patterns of expression of HLA class I free heavy chains in healthy individuals and raised expression in spondyloarthropathy patients point to physiological and pathological roles.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76e68213c6817d4a3ce774827d8931ce"><gtr:id>76e68213c6817d4a3ce774827d8931ce</gtr:id><gtr:otherNames>Raine T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>305DF7264A3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5C8DA35-C130-4E40-AA8C-37130CBABA5D</gtr:id><gtr:title>Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d588795d77f60abde584e2f6fc73eb3"><gtr:id>2d588795d77f60abde584e2f6fc73eb3</gtr:id><gtr:otherNames>Kasprowicz V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>C024406CBA1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BF72183-C0F7-49F7-8936-20979A6C240C</gtr:id><gtr:title>Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ea327ab0613a3d1a48ee62ad119a220"><gtr:id>5ea327ab0613a3d1a48ee62ad119a220</gtr:id><gtr:otherNames>Kollnberger S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>0F5993FA372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E32A073-B09E-4915-BBB7-4FF2576E6A9B</gtr:id><gtr:title>The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ea327ab0613a3d1a48ee62ad119a220"><gtr:id>5ea327ab0613a3d1a48ee62ad119a220</gtr:id><gtr:otherNames>Kollnberger S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>bcAQbY8gwNF</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U137884185</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>986F1CAE-CC43-4D59-8F85-A91971E4C4BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Other</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>